NCT03052920

Brief Summary

This longitudinal study evaluates the possible benefit of cochlear implantation in the poor ear of adults with asymmetric hearing loss who continue to use a hearing aid in the better hearing ear.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 14, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

July 28, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2021

Completed
7 months until next milestone

Results Posted

Study results publicly available

October 18, 2021

Completed
Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

3.3 years

First QC Date

February 9, 2017

Results QC Date

September 1, 2021

Last Update Submit

March 9, 2026

Conditions

Keywords

cochlear implantasymmetric hearing loss

Outcome Measures

Primary Outcomes (2)

  • Change in Poor Ear Alone CNC Monosyllabic Word Understanding in Quiet

    Group mean difference in CNC monosyllabic word understanding score in quiet with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (CNC scored on a scale from 0% to 100%; Higher scores are better.)

    Pre-implant and 6 months post-implant

  • Change in Poor Ear Alone Soundfield Thresholds

    Group mean difference in soundfield thresholds (dB HL average across frequency range) with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (Measurable decibels in hearing level (dB HL) generally range from -10 dB to 120 dB; Lower levels are better.)

    Pre-implant and 6 months post-implant

Secondary Outcomes (13)

  • Change in Sound Localization

    Pre-implant and 6 months post-implant

  • Change in AzBio Sentences at 50 Decibels (dB) Sound Pressure Level (SPL)

    Pre-implant and 6 months post-implant

  • Change in AzBio Sentence Scores at 60 dB SPL and 4-talker Babble at +8 dB Signal-to-noise Ratio (SNR)

    Pre-implant and 6 months post-implant

  • Change in Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentence Understanding With Noise to the Better Ear

    Pre-implant and 6 months post-implant

  • Change in AzBio Sentence Scores at 60 dB SPL for the Poor Ear Alone

    Pre-implant and 6 months post-implant

  • +8 more secondary outcomes

Study Arms (1)

Cochlear Implantation

EXPERIMENTAL

Cochlear implantation of the poor hearing ear

Device: Cochlear implant

Interventions

Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.

Also known as: Cochlear America, Advanced Bionics, MED-EL
Cochlear Implantation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • English as the native language
  • Have a desire for functional binaural hearing
  • Have failed a previous hearing aid (HA) treatment for asymmetric hearing loss (BiCROS or poor ear HA) or willing to complete a trial if necessary
  • Willingness to comply with all study requirements
  • Ability to provide informed consent
  • Poor ear (ear to be implanted):
  • Pure-tone average (PTA) at .5, 1 and 2 kilohertz (kHz) \> 70 dB HL (hereafter referred to as severe to profound hearing loss - SPHL)
  • Aided word recognition score (CNC Word Test) at 60 dB SPL ≤ 30%
  • Duration of SPHL ≥ 6 months
  • Onset of hearing loss ≥ 6 years of age
  • Better ear:
  • PTA at .5, 1, 2, 4 kHz of 40 to 70 dB HL
  • Currently using a HA
  • Aided word recognition score (CNC Word Test) at 60 dB SPL \> 40%
  • +1 more criteria

You may not qualify if:

  • Medical condition that contraindicates surgery
  • Actively using an implantable device in the ear to be implanted
  • Known cochlear malformation or obstruction that would preclude full insertion of the electrode array in the ear to be implanted
  • Hearing loss of neural or central origin
  • Unrealistic expectations related to the benefits and limitations of cochlear implantation
  • Unwillingness or inability to comply with all investigational requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

House Clinic

Los Angeles, California, 90057, United States

Location

Saint Luke's Midwest Ear Institute

Kansas City, Missouri, 64111, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

New York University School of Medicine

New York, New York, 10016, United States

Location

Related Publications (1)

  • Sampathkumar R, Kaehne A, Kumar N, Kameswaran M, Irving R. Systematic review of cochlear implantation in adults with asymmetrical hearing loss. Cochlear Implants Int. 2021 Nov;22(6):311-329. doi: 10.1080/14670100.2021.1936363. Epub 2021 Jun 14.

MeSH Terms

Conditions

Hearing Loss

Interventions

Cochlear Implants

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Neural ProsthesesImplantable NeurostimulatorsElectrodes, ImplantedElectrodesElectrical Equipment and SuppliesEquipment and SuppliesProstheses and ImplantsHearing AidsSensory Aids

Results Point of Contact

Title
Jill B Firszt, PI
Organization
Washington University in St. Luis

Study Officials

  • Jill B Firszt, PhD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2017

First Posted

February 14, 2017

Study Start

July 28, 2017

Primary Completion

November 17, 2020

Study Completion

March 10, 2021

Last Updated

March 11, 2026

Results First Posted

October 18, 2021

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations